Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients

References

• Gordon C. Long-term complications of systemic lupus erythematosus. Rheumatology 2002; 41: 1095–1100
   PubMed Web of Science ®Google Scholar
• Frostegard J, Svenungsson E, Wu R, Gunnarsson I, Lundberg IE, Klareskog L, Horkko S, Witztum JL. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum 2005; 52: 192–200
   PubMed Web of Science ®Google Scholar
• Alves JD, Ames PRJ. Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome. Immunobiology 2003; 207: 23–28
   PubMed Web of Science ®Google Scholar
• Avalos I, Chung CP, Oeser A, Milne GL, Morrow JD, Gebretsadik T, Shintani A, Yu C, Stein CM. Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Lupus 2007; 16: 195–200
   PubMed Web of Science ®Google Scholar
• de Carvalho JF, Bonfa E, Borba EF. Systemic lupus erythematosus and ‘lupus dyslipoproteinemia’. Autoimmunity Rev 2008; 7: 246–250
   PubMed Web of Science ®Google Scholar
• Sheikh Z, Ahmad R, Sheikh N, Ali R. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies. Autoimmunity 2007; 40: 512–520
   PubMed Web of Science ®Google Scholar
• Horkko S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Branch DW, Palinski W, Witztum JL. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of low density lipoprotein. J Clin Invest 1996; 98: 815–825
   PubMed Web of Science ®Google Scholar
• Tam LS, Li EK, Leung VYF, Griffith JF, Benzie IFF, Lim PL, Whitney B, Lee VWY, Lee KKC, Thomas GN, Tomlinson B. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. J Rheumatol 2004; 32: 275–282
   Web of Science ®Google Scholar
• Nuttall SL, Heaton S, Piper MK, Martin U, Gordon C. Cardiovascular risk in systemic lupus erythematosus—evidence of increased oxidative stress and dyslipidaemia. Rheumatology 2003; 42: 758–762
   PubMed Web of Science ®Google Scholar
• Ames PRJ, Alves J, Murat I, Isenberg DA, Nourooz-Zadeh J. Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement. Rheumatology 1999; 38: 529–534
   PubMed Web of Science ®Google Scholar
• Evans MD, Cooke MS, Akil M, Samanta A, Lunec J. Aberrant processing of oxidative DNA damage in systemic lupus erythematosus. Biochem Biophys Res Commun 2000; 273: 894–898
   PubMed Web of Science ®Google Scholar
• Lunec J, Herbert K, Blount S, Griffiths HR, Emery P. 8-Hydroxydeoxyguanosine. A marker of oxidative damage in systemic lupus erythematosus. FEBS Lett 1994; 348: 131–138
   PubMed Web of Science ®Google Scholar
• Davies MJ. The oxidative environment and protein damage. Biochim Biophys Acta 2005; 1703: 93–109
   PubMed Web of Science ®Google Scholar
• Davies MJ, Fu S, Wang H, Dean RT. Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radic Biol Med 1999; 27: 1151–1163
   PubMed Web of Science ®Google Scholar
• Beal MF. Oxidative modified proteins in aging and disease. Free Radic Biol Med 2002; 32: 797–803
   PubMed Web of Science ®Google Scholar
• Fu S, Davies MJ, Stocker R, Dean RT. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J 1998; 333: 519–525
   PubMed Web of Science ®Google Scholar
• Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of disease-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003; 34: 1563–1574
   PubMed Web of Science ®Google Scholar
• Heinecke JW. Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. J Lab Clin Med 1999; 133: 321–325
   PubMed Web of Science ®Google Scholar
• Lorber A, Pearson CM, Meredith WL, Gantz-Mandell LE. Serum sulfhydryl determinations and significance in connective tissue diseases. Ann Intern Med 1964; 61: 423–434
   PubMed Web of Science ®Google Scholar
• Lorber A, Bovy RA, Chang CC. Sulfhydryl deficiency in connective tissue disorders: correlation with disease activity and protein alterations. Metabolism 1971; 20: 446–455
   PubMed Web of Science ®Google Scholar
• Oates JC, Christensen EF, Reilly CM, Self SE, Gilkeson GS. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. P Assoc Am Physician 1999; 111: 611–621
   PubMedGoogle Scholar
• Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997; 324: 1–18
   PubMed Web of Science ®Google Scholar
• Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997; 272: 20313–20316
   PubMed Web of Science ®Google Scholar
• Morgan PE, Sturgess AD, Davies MJ. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum 2005; 52: 2069–2079
   PubMed Web of Science ®Google Scholar
• Morgan PE, Sturgess AD, Hennessy A, Davies MJ. Serum protein oxidation and apolipoprotein CIII levels in people with systemic lupus erythematosus with and without nephritis. Free Radic Res 2007; 41: 1301–1312
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 1997; 40: 1725
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630–640
   PubMed Web of Science ®Google Scholar
• Gladman DD, Urowitz MB, Kagal A, Hallett D. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol 2000; 27: 377–379
   PubMed Web of Science ®Google Scholar
• Hu ML. Measurement of protein thiol groups and glutathione in plasma. Method Enzymol 1994; 233: 380–385
   PubMed Web of Science ®Google Scholar
• Kleinman WA, Richie JPJ. Status of glutathione and other thiols and disulfides in human plasma. Biochem Pharmacol 2000; 60: 19–29
   PubMed Web of Science ®Google Scholar
• Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850–858
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG. A two-dimensional gel database of human plasma proteins. Electrophoresis 1991; 12: 883–906
   PubMed Web of Science ®Google Scholar
• Hughes GJ, Frutiger S, Paquet N, Ravier F, Pasquali C, Sanchez JC, James R, Tissot JD, Bjellqvist B, Hochstrasser DF. Plasma protein map: an update by microsequencing. Electrophoresis 1992; 13: 707–714
   PubMed Web of Science ®Google Scholar
• Ward MM, Leigh JP. Pooled time series regression analysis in longitudinal studies. J Clin Epidemiol 1993; 46: 645–659
   PubMed Web of Science ®Google Scholar
• Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005; 41: 1211–1219
   PubMed Web of Science ®Google Scholar
• Carballal S, Radi R, Kirk MC, Barnes S, Freeman BA, Alvarez B. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry-US 2003; 42: 9906–9914
   PubMed Web of Science ®Google Scholar
• DeMaster EG, Quast BJ, Redfern B, Nagasawa HT. Reaction of nitric oxide with the free sulfhydryl group of human serum albumin yields a sulfenic acid and nitrous oxide. Biochemistry-US 1995; 34: 11494–11499
   PubMed Web of Science ®Google Scholar
• Hayashi T, Era S, Kawai K, Imai H, Nakamura K, Onda E, Yoh M. Observation for redox state of human serum and aqueous humor albumin from patients with senile cataract. Pathophysiology 2000; 6: 237–243
   Google Scholar
• Sogami M, Era S, Nagoka S, Kuwata K, Kida K, Shigemi J, Miura K, Suzuki E, Muto Y, Tomita E, Hayano S, Sawada S, Noguchi K, Miyata S. High-performance liquid chromatographic studies on non-mercapt in equilibrium with mercapt conversion of human serum albumin. II. J Chromatogr 1985; 332: 19–27
   PubMed Web of Science ®Google Scholar
• Kadota K, Yui Y, Hattori R, Murohara Y, Kawai C. Decreased sulfhydryl groups of serum albumin in coronary artery disease. Jpn Circ J 1991; 55: 937–941
   PubMedGoogle Scholar
• Rottoli P, Magi B, Cianti R, Bargagli E, Vagaggini C, Nikiforakis N, Pallini V, Bini L. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 2005; 5: 2612–2618
   PubMed Web of Science ®Google Scholar
• Chapman ML, Rubin BR, Gracy RW. Increased carbonyl content of proteins in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1989; 16: 15–18
   PubMed Web of Science ®Google Scholar
• Chevion M, Berenshtein E, Stadtman ER. Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res 2000; 33: S99–S108
   PubMed Web of Science ®Google Scholar
• Shmerling RH. Diagnostic tests for rheumatic disease: clinical utility revisited. Southern Med J 2005; 98: 704–711
   PubMed Web of Science ®Google Scholar
• van Leeuwen MA, van Rijswijk MH. Acute phase proteins in the monitoring of inflammatory disorders. Bailliere Clin Rheum 1994; 8: 531–552
   PubMedGoogle Scholar
• Jones IR, Owens DR, Williams S, Ryder RE, Birtwell AJ, Jones MK, Gicheru K, Hayes TM. Glycosylated serum albumin: an intermediate index of diabetic control. Diabetes Care 1983; 6: 501–503
   PubMed Web of Science ®Google Scholar
• Dean RT, Armstrong SG, Fu S, Jessup W. Oxidised proteins and their enzymatic proteolysis in eukaryotic cells: a critical appraisal. Free radicals in the environment, medicine and toxicology, H Nohl, H Esterbauer, C Rice-Evans. Richelieu Press, London 1994; 47–79
   Google Scholar
• Glaser CB, Karic L, Parmelee S, Premachandra BR, Hinkston D, Abrams WR. Studies on the turnover of methionine oxidized alpha-1-protease inhibitor in rats. Am Rev Respir Dis 1987; 136: 857–861
   PubMedGoogle Scholar
• Grune T, Jung T, Merker K, Davies KJA. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and ‘aggresomes’ during oxidative stress, aging and disease. Int J Biochem Cell B 2004; 36: 2519–2530
   PubMed Web of Science ®Google Scholar
• Hawkins CL, Davies MJ. The role of aromatic amino acid oxidation, protein unfolding, and aggregation in the hypobromous acid-induced inactivation of trypsin inhibitor and lysozyme. Chem Res Toxicol 2005; 18: 1669–1677
   PubMed Web of Science ®Google Scholar
• Hawkins CL, Davies MJ. Inactivation of protease inhibitors and lysozyme by hypochlorous acid: role of side-chain oxidation and protein unfolding in loss of biological function. Chem Res Toxicol 2005; 18: 1600–1610
   PubMed Web of Science ®Google Scholar
• Choi J, Sullards MC, Olzmann JA, Rees HD, Weintraub ST, Bostwick DE, Gearing M, Levey AI, Chin LS, Li L. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 2006; 281: 10816–10824
   PubMed Web of Science ®Google Scholar
• Stadtman ER. Cyclic oxidation and reduction of methionine residues of proteins in antioxidant defense and cellular regulation. Arch Biochem Biophys 2004; 423: 2–5
   PubMed Web of Science ®Google Scholar
• Schoneich C. Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease. Biochim Biophys Acta 2005; 1703: 111–119
   PubMed Web of Science ®Google Scholar